Evidence map›Paper›PMID 31809512›Full record

ArticlePloS one2019

Multiscale analysis for patterns of Zika virus genotype emergence, spread, and consequence.

Monica K Borucki, Nicole M Collette, Lark L Coffey, Koen K A Van Rompay, Mona H Hwang, James B Thissen, Jonathan E Allen, Adam T Zemla

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Brazilian Protocol for Sexually Transmitted Infections 2020: Zika virus infection.Revista da Sociedade Brasileira de Medicina Tropical · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Monica K BoruckiPhysical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0003-2924-2313
Nicole M CollettePhysical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.
Lark L CoffeyDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, United States of America.
Koen K A Van RompayDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, United States of America.
Mona H HwangPhysical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.
James B ThissenPhysical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.ORCID 0000-0002-4693-5886
Jonathan E AllenComputations Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.
Adam T ZemlaComputations Directorate, Lawrence Livermore National Laboratory, Livermore, California, United States of America.
Lawrence Livermore National Laboratory · USUniversity of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Development of a nonhuman primate model of fetal Zika virus infection and diseaseR21AI129479 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI VAN ROMPAY, KOEN K · 2017 to 2018
$1.9M
NIAID NIH HHS R21 AI129479NIH HHS P51 OD011107
6 · The paper itself

Abstract

The question of how Zika virus (ZIKV) changed from a seemingly mild virus to a human pathogen capable of microcephaly and sexual transmission remains unanswered. The unexpected emergence of ZIKV's pathogenicity and capacity for sexual transmission may be due to genetic changes, and future changes in phenotype may continue to occur as the virus expands its geographic range. Alternatively, the sheer size of the 2015-16 epidemic may have brought attention to a pre-existing virulent ZIKV phenotype in a highly susceptible population. Thus, it is important to identify patterns of genetic change that may yield a better understanding of ZIKV emergence and evolution. However, because ZIKV has an RNA genome and a polymerase incapable of proofreading, it undergoes rapid mutation which makes it difficult to identify combinations of mutations associated with viral emergence. As next generation sequencing technology has allowed whole genome consensus and variant sequence data to be generated for numerous virus samples, the task of analyzing these genomes for patterns of mutation has become more complex. However, understanding which combinations of mutations spread widely and become established in new geographic regions versus those that disappear relatively quickly is essential for defining the trajectory of an ongoing epidemic. In this study, multiscale analysis of the wealth of genomic data generated over the course of the epidemic combined with in vivo laboratory data allowed trends in mutations and outbreak trajectory to be assessed. Mutations were detected throughout the genome via deep sequencing, and many variants appeared in multiple samples and in some cases become consensus. Similarly, amino acids that were previously consensus in pre-outbreak samples were detected as low frequency variants in epidemic strains. Protein structural models indicate that most of the mutations associated with the epidemic transmission occur on the exposed surface of viral proteins. At the macroscale level, consensus data was organized into large and interactive databases to allow the spread of individual mutations and combinations of mutations to be visualized and assessed for temporal and geographical patterns. Thus, the use of multiscale modeling for identifying mutations or combinations of mutations that impact epidemic transmission and phenotypic impact can aid the formation of hypotheses which can then be tested using reverse genetics.

Indexed as

Mutation RateDatabases, GeneticDatasets as TopicDisease OutbreaksGenome, ViralGenotypeGeographyHigh-Throughput Nucleotide SequencingHumansModels, MolecularPhylogenyRNA, ViralSpatio-Temporal AnalysisViral Nonstructural ProteinsViral Structural ProteinsZika VirusRNA, ViralViral Nonstructural ProteinsViral Structural Proteins

Identifiers

PMID31809512
PMCPMC6897431
OpenAlexW2993024586

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.